2010 Scrip 100 - Can China retain its API sourcing appeal?
This article was originally published in Scrip
Executive Summary
China has a burgeoning API manufacturing base, albeit one focused largely on achieving quick profits in the domestic sector. Robert Kennedy's analysis reveals a striking number of Chinese companies that are gearing up to supply pharmaceutical ingredients to the regulated markets of the west.